支架置入术与强化药物治疗预防颅内动脉狭窄患者复发性卒中试验(Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis,SAMMPRIS)的早期结果表明,14.7%(33/224)的支架置人...
由于支架置入术组30d卒中发生率高于预期,在颅内动脉狭窄患者中应用支架置入术和强化药物治疗预防卒中(Stenting and Aggressive Medical Managmaent for the Prevention of stroke in Intracranial Stenosis,SAMM-PRIS)试验的登记...